Ad is loading...
IVVD
Price
$0.71
Change
+$0.01 (+1.43%)
Updated
Nov 22, 03:24 PM (EDT)
125 days until earnings call
VIR
Price
$7.25
Change
+$0.29 (+4.17%)
Updated
Nov 22, 03:40 PM (EDT)
90 days until earnings call
Ad is loading...

IVVD vs VIR

Header iconIVVD vs VIR Comparison
Open Charts IVVD vs VIRBanner chart's image
Invivyd
Price$0.71
Change+$0.01 (+1.43%)
Volume$100
CapitalizationN/A
Vir Biotechnology
Price$7.25
Change+$0.29 (+4.17%)
Volume$1.88K
CapitalizationN/A
IVVD vs VIR Comparison Chart
Loading...
IVVD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
IVVD vs. VIR commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVVD is a Hold and VIR is a Hold.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (IVVD: $0.70 vs. VIR: $6.95)
Brand notoriety: IVVD and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IVVD: 151% vs. VIR: 164%
Market capitalization -- IVVD: $83.71M vs. VIR: $957.15M
IVVD [@Biotechnology] is valued at $83.71M. VIR’s [@Biotechnology] market capitalization is $957.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IVVD’s FA Score shows that 1 FA rating(s) are green whileVIR’s FA Score has 0 green FA rating(s).

  • IVVD’s FA Score: 1 green, 4 red.
  • VIR’s FA Score: 0 green, 5 red.
According to our system of comparison, VIR is a better buy in the long-term than IVVD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IVVD’s TA Score shows that 4 TA indicator(s) are bullish while VIR’s TA Score has 4 bullish TA indicator(s).

  • IVVD’s TA Score: 4 bullish, 6 bearish.
  • VIR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, VIR is a better buy in the short-term than IVVD.

Price Growth

IVVD (@Biotechnology) experienced а -11.47% price change this week, while VIR (@Biotechnology) price change was -19.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.10%. For the same industry, the average monthly price growth was -5.02%, and the average quarterly price growth was +3.97%.

Reported Earning Dates

IVVD is expected to report earnings on Mar 27, 2025.

VIR is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (+2.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIR($957M) has a higher market cap than IVVD($83.7M). VIR YTD gains are higher at: -30.915 vs. IVVD (-82.239). IVVD has higher annual earnings (EBITDA): -232.89M vs. VIR (-562.68M). VIR has more cash in the bank: 914M vs. IVVD (107M). IVVD has less debt than VIR: IVVD (1.63M) vs VIR (113M). VIR has higher revenues than IVVD: VIR (62M) vs IVVD (11.6M).
IVVDVIRIVVD / VIR
Capitalization83.7M957M9%
EBITDA-232.89M-562.68M41%
Gain YTD-82.239-30.915266%
P/E RatioN/AN/A-
Revenue11.6M62M19%
Total Cash107M914M12%
Total Debt1.63M113M1%
TECHNICAL ANALYSIS
Technical Analysis
IVVDVIR
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 17 days ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
IVVD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYLDX185.763.87
+2.13%
Rydex Dow 2x Strategy A
FVCSX41.890.79
+1.92%
Fidelity Advisor Value Strategies C
FLCPX24.630.14
+0.57%
Fidelity SAI US Large Cap Index
WLCIX15.62N/A
N/A
Allspring Large Company Value Inst
FSISX8.38N/A
N/A
Fidelity SAI International Sm Cp Idx

IVVD and

Correlation & Price change

A.I.dvisor indicates that over the last year, IVVD has been loosely correlated with ENTO. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if IVVD jumps, then ENTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVVD
1D Price
Change %
IVVD100%
-8.89%
ENTO - IVVD
57%
Loosely correlated
+3.49%
VIR - IVVD
37%
Loosely correlated
+3.12%
CDTX - IVVD
36%
Loosely correlated
+15.41%
AXON - IVVD
34%
Loosely correlated
+3.52%
MDGL - IVVD
32%
Poorly correlated
+3.83%
More

VIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with ADPT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then ADPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
+3.12%
ADPT - VIR
52%
Loosely correlated
-1.13%
CRSP - VIR
51%
Loosely correlated
-2.05%
AVIR - VIR
47%
Loosely correlated
+2.85%
AXON - VIR
47%
Loosely correlated
+3.52%
TECH - VIR
47%
Loosely correlated
+3.39%
More